INTRODUCTION
============

The skeletal muscle fiber is a syncytium resulting from the fusion of hundreds of myoblasts ([@B1]). Muscle cells represent the main vertebrate cell type and are specialized to contract, and thus are responsible for voluntary movements. During muscle development or regeneration, nuclei are first found in the center of myotubes and then migrate to the periphery of mature skeletal myofibers ([@B4]). Proper nuclear positioning is required for muscle function ([@B24]), and nuclear mispositioning is a hallmark of different muscle disorders, such as centronuclear myopathies ([@B20]).

Multiple nuclear movement events occur during myofiber development to localize precisely each individual nucleus ([@B8]; [@B24]; [@B34], [@B35]; [@B18]). The first nuclear migration event in muscle development takes place just after fusion, when the nucleus from a fusing myoblast rapidly migrates toward the center of the myotube. This process is called centration ([@B8]). Second, nuclei spread to become evenly spaced along the length of developing myotubes ([@B24]), a step called spreading. These two events were proposed to rely on the microtubule (MT) network and on some motor proteins. Finally, as myotubes mature into myofibers, nuclei migrate from the center to the periphery of the fiber by a mechanism dependent on N-Wasp, an actin regulator, and amphiphysin-2, a BAR protein mutated in centronuclear myopathies. This nuclear migration is termed dispersion ([@B18]). Nuclear positioning in cells appears to be a key mechanism required for multiple developmental processes in order to maintain functionally efficient muscle or brain ([@B12]). These processes are described as being driven by MTs or actin ([@B19]). Even though recent advances in understanding nuclei position in developing muscle cells reveal an important role of MTs and some MT motors (kinesins and dyneins; [@B8]; [@B24]; [@B34]), the contribution of other MT motors to nuclei position during myofiber formation remains unexplored.

Here we present a comprehensive analysis of MT-related molecular motor involvement in nuclear spreading during myofiber development. We use time-lapse microscopy combined with a small interfering RNA (siRNA) screen targeting all MT-related molecular motors (kinesins and dyneins) of the mouse genome to identify their involvement. These results highlight the variable effects of molecular motors on particular mechanisms in the early phases of myofiber development, such as nuclear alignment, time in motion, and speed of nuclei inside myotubes.

RESULTS AND DISCUSSION
======================

Nuclear movements contribute to nuclei alignment inside myotubes
----------------------------------------------------------------

Nuclear movements occur in both primary differentiated muscle cells and C2C12s ([Figure 1A](#F1){ref-type="fig"}; [@B17]; [@B8]; [@B24]; [@B34]). We therefore used C2C12 muscle cells ([@B8]), stably expressing green fluorescent protein (GFP)--histone H1, to quantify nuclear behaviors during myotube formation using time-lapse microscopy. Nuclei within myotubes follow different behaviors, suggesting that multiple forces are applied to nuclei, driving their displacement along developing myofibers. To better characterize these nuclear migrations, we tracked each nucleus inside myotubes during the first 4 d of myofiber development and analyzed nuclear movements using SkyPad ([@B7]) to extract speed and percentage of time in motion. We also quantified nuclei distribution in myotubes to measure whether the resulting forces on each nucleus lead to a "nuclei alignment" organization ([@B24]). Finally, we analyzed fusion index to correlate defects in nuclear behavior with differentiation. During differentiation, nuclei progressively reduce their movements (Supplemental Figure S1A), and after 4 d, nuclei are mostly spread along the myotube axis ([Figures 1B](#F1){ref-type="fig"} and [2C](#F2){ref-type="fig"}; [@B24]). Reduction of speed and time in motion during differentiation suggests that nuclear movement is not driven by a unique mechanism. We therefore decided to perform our analysis of nuclear movement between 60 and 75 h of differentiation, where nuclei inside myotubes move 55% of the time (±1.3) at a speed of 0.278 μm/min (± 0.1), similar to previously published results on nuclei speed ([Figure 1C](#F1){ref-type="fig"}; [@B34]).

![Role of MTs and actin in nuclear movement inside myotubes. (A) Frames from time-lapse two-channel movies (phase contrast and fluorescence) of differentiated GFP-H1-C2 cells in presence or absence of the indicated drugs (Supplemental Movie S1). The first frame of each representative 14-h movie shows a myotube with GFP-H1-C2 nuclei (green); the white rectangle corresponds to the region used to create the adjacent kymograph. (B) Histogram of nuclear distribution analysis in C2C12 myotubes: nontreated (Control), treated with 75 nM nocodazole (Ndz), 100 nM Taxol (Taxol), 200 nM jasplakinolide (Jaspla), or 10 nM cytochalasin D (CytoD), or transfected with GFP-spastin. Nuclear distribution is quantified as "aligned" if \>70% of nuclei are aligned along the same axis; "aggregated" if \>70% of nuclei do not align along the same axis; and "other" if nuclei are both aggregated and aligned in the same myotube. (C) Speed and (D) percentage of time in motion of nuclei inside C2C12 myotubes 2--3 d old in nontreated (Control), treated with 75 nM Ndz, 100 nM Taxol, 200 nM Jaspla, or 10 nM CytoD conditions or transfected with GFP-spastin. Red line indicates the median. Between 53 (CytoD) and 181 (Ctr) nuclei were monitored from three different experiments. Error bars, SEM. \*\*\**p* \< 0.001, \*\**p* \< 0.01. (E) STA graph; color is representative of the *p* value after one-way analysis of variance (ANOVA) statistical test toward a decrease compared to control. \*\*\**p* \< 0.001, \*\**p* \< 0.01, \**p* \< 0.05.](865fig1){#F1}

![MT motor siRNA screen for nuclear movement and alignment in myotubes. (A) STA graph after silencing of kinesin or dynein members for nuclei inside myotubes after 3 d of differentiation. Colors are representative of the *p* values after one-way ANOVA statistical test toward a decrease (red) and increase (green) compared to control. \*\*\**p* \< 0.001, \*\**p* \< 0.01, \**p* \< 0.05. The percentage of remaining mRNA after silencing is also indicated. (B) Venn diagram to summarize the results obtained with siRNA screen, showing the distribution of genes implicated in one or more of the nuclear behaviors. Purple, proteins implicated in minus end--directed motion; blue, plus end--directed proteins. (C) Distribution of nuclei in myotubes and (D) number of nuclei per myotubes in five different conditions (Ctr, Kif5b, Kif1a, Kif1c, Kif9, and Kif21b siRNAs) after 88 h of differentiation. Spreading factor is the ratio between observed average distance and theoretical maximum distance between nuclei (41--76 myotubes). (E) Representative image of myotubes in each condition.](865fig2){#F2}

Nuclear movement and alignment are mainly MT dependent
------------------------------------------------------

We first investigated the contribution of actin and MT networks to nuclear behavior inside myotubes. Because these two networks are essential for fusion ([@B15]; [@B8]), we applied drugs affecting MTs (nocodazole and Taxol) and actin (cytochalasin D and jasplakinolide) 3 d after differentiation. After testing a range of concentrations, we used concentrations that did not affect global shape of myotubes but did impair cytoskeletal dynamics ([@B3]; [@B28]; [@B32]; [@B5]; [@B27]). Surprisingly, some parameters, such as time in motion, are only slightly modified by actin-targeted drugs. Percentage of time in motion decreased from 55% in control to 34% in 25 nM cytochalasin D and to 45% in 200 nM jasplakinolide ([Figure 1, A and D](#F1){ref-type="fig"}). However, other characteristics are more drastically affected, such as nuclei speed, which decreased to 0.20 μm/min in cytochalasin D-- and 0.23 μm/min in jasplakinolide-treated myotubes, compared with 0.27 μm/min in controls ([Figure 1C](#F1){ref-type="fig"} and Supplemental Movie S1). Of interest, drugs targeting the actin network did not affect the alignment of nuclei in myotubes ([Figure 1C](#F1){ref-type="fig"}).

To hamper MT dynamics without affecting the overall shape of myotubes, we used drugs at low concentrations (75 nM nocodazole and 100 nM Taxol). Some parameters are highly modified during the first 24-h exposure, such as a dramatic decrease in the percentage of time in motion compared with control ([Figure 1, A and D](#F1){ref-type="fig"}). Nuclear speed inside myotubes also decreases in nocodazole- and Taxol-treated myotubes ([Figure 1C](#F1){ref-type="fig"} and Supplemental Movie S1A). To confirm MT involvement in maintaining these parameters, we overexpressed constitutively active spastin, a MT-severing protein ([@B33]). We previously found that expression of spastin, but not the non--MT-severing mutant, prevents nuclear movement after fusion ([@B8]). We now found that ectopic expression of spastin in myotubes dramatically reduces nuclear motion and organization ([Figure 1, B--D](#F1){ref-type="fig"}). To facilitate our readout, we represented the three measured parameters in an STA graph ([s]{.ul}peed, [t]{.ul}ime in motion, and [a]{.ul}lignment), as represented in [Figure 1E](#F1){ref-type="fig"}. These results describe the initial step of myofiber formation---when nuclei move extensively to establish an elongated myotube containing aligned nuclei. These results demonstrate the paramount role of dynamic MTs in nuclear movement within the myotube.

Identification of MT motors involved in nuclear spreading in myotubes
---------------------------------------------------------------------

Next we sought to identify the MT-related molecular motors implicated in nuclear movement behavior. We performed an siRNA screen with three different sequences for each known kinesin and cytoplasmic dynein subunit (56 proteins; [Table 1](#T1){ref-type="table"}). STA parameters were measured in three different experiments on an area of 3.79 mm², corresponding to a single field of view under the microscope at a 4× magnification. We also quantified the fusion index to monitor the effect of protein silencing on the fusion process (Supplemental Figure S1C). At 36 h after silencing, cells were induced to differentiate into myotubes. Nuclear trajectories were analyzed using SkyPad ([@B7]) from 60 to 75 h after the induction of differentiation (Supplemental Figure S2, A and B). At this time, the initial fusion events and their associated nuclear movements (centration) are terminated, and myotubes contain enough nuclei to be monitored for their displacements. The last frame of each movie was used to quantify nuclei alignment in myotubes and fusion index (Supplemental Figures S1C and S2C). The data were compiled in an STA graph, allowing an easy overview of the effect of all kinesins and dynein members on nuclear movement behavior ([Figure 2A](#F2){ref-type="fig"}). In our conditions, cells divide at least once before differentiation. Therefore depletion of motors implicated in the cell division process leads to massive cell death: Kif11 (Eg5), which is an establisher of the bipolar spindle ([@B2]), Kif23 (MKLP-1), and Kif12, which is known to be essential for cytokinesis ([@B21]; [@B38]). Depletion of two other kinesins leads to failure in differentiation: Kifc3, responsible for Golgi positioning and integration ([@B36]), and Kif3c, a kinesin whose function remains to be elucidated ([@B37]). We were still able to quantify the fusion index for the remaining cells, but the nuclei number per myotube (two to five) was too low to allow correct quantification of the other STA parameters. Of interest, dynein motor inhibition does not lead to any gross cell fusion defects ([Figure 2A](#F2){ref-type="fig"} and Supplemental Figure S1C). Furthermore, we did not find any correlation between defects in nuclei behavior and fusion index. For example, Kif5b or Kif20a depletion affects uniquely nuclear movement or fusion index, respectively. It is important to note that efficiency of knockdown might have affected the functional readouts. We therefore measured the percentage of remaining mRNA for most targets by Taqman ([Figure 2A](#F2){ref-type="fig"}) or at the protein level by Western blot (Supplemental Figure S1B).

###### 

siRNA sequences and Taqman probes used for each molecular motor.

  RefSeq accession number   Gene symbol   Sense siRNA sequence    Antisense siRNA sequence   Taqman assay ID
  ------------------------- ------------- ----------------------- -------------------------- -----------------
  NM_008440                 Kif1a         GGACAUCAACUAUGCCUCUtt   AGAGGCAUAGUUGAUGUCCtc      Mm00492863_m1
                                          GGAAACAGAGAAGAUCAUUtt   AAUGAUCUUCUCUGUUUCCtt      
                                          CCAAGUCCUUCAUCGAAUAtt   UAUUCGAUGAAGGACUUGGtc      
  NM_207682                 Kif1b         CGGGCUGAUUCAACUGGUGtt   CACCAGUUGAAUCAGCCCGtt      Mm00801827_m1
                                          CCUCAAUGAAGACCCAUUAtt   UAAUGGGUCUUCAUUGAGGtt      
                                          GGAUGGAAUUACAAGGGUUtt   AACCCUUGUAAUUCCAUCCtt      
  NM_153103                 Kif1c         CCUUCGACUAUUCUUACUGtt   CAGUAAGAAUAGUCGAAGGtg      Mm00462184_m1
                                          GGAAACAGAGAAGAUCAUAtt   UAUGAUCUUCUCUGUUUCCtg      
                                          CCAUGUUUUCCGCUUCAAUtt   AUUGAAGCGGAAAACAUGGtt      
  NM_008442                 Kif2a         GGGAAUUUAUGCAUUAGCAtt   UGCUAAUGCAUAAAUUCCCtt      Mm00515233_m1
                                          CGCAGAUCAAUUUUCAUAGtt   CUAUGAAAAUUGAUCUGCGtt      
                                          GCUCCUAAUGAAAUGGUUUtt   AAACCAUUUCAUUAGGAGCtg      
  NM_134471                 Kif2c         GGAGGUACCACAAAAGGCAtt   UGCCUUUUGUGGUACCUCCtt      Mm00728630_s1
                                          GGCAAAGAGAUUGACAUUGtt   CAAUGUCAAUCUCUUUGCCtt      
                                          GCAGAAAUUAACAAGUCUCtt   GAGACUUGUUAAUUUCUGCtc      
  NM_008443                 Kif3a         GGGCGACACAAGGUUUUUGtt   CAAAAACCUUGUGUCGCCCtc      Mm01288585_m1
                                          GGGACCAAGCAGGUAAAAAtt   UUUUUACCUGCUUGGUCCCtt      
                                          CCGUAAUUGAUUCUUUACUtt   AGUAAAGAAUCAAUUACGGtc      
  NM_008444                 Kif3b         GGAUUUGUCUUCUUUUGUCtt   GACAAAAGAAGACAAAUCCtt      Mm00492891_m1
                                          GGUGGUAGAUGCGGAUGUGtt   CACAUCCGCAUCUACCACCtt      
                                          GGGUUUCAAUGGCACAAUUtt   AAUUGUGCCAUUGAAACCCtg      
  NM_008445                 Kif3c         GGAGAAUCCUGAAACAGGGtt   CCCUGUUUCAGGAUUCUCCtt      Mm00492900_m1
                                          GGAAGAUGAUAACAACAACtt   GUUGUUGUUAUCAUCUUCCtc      
                                          CCGGCUAUCUUUGAGAUGGtt   CCAUCUCAAAGAUAGCCGGtg      
  NM_008446                 Kif4          GGUGGUGGUUGGUAAUGAUtt   AUCAUUACCAACCACCACCtg      Mm00492908_m1
                                          GGAAGAGGUCUUUAAUACAtt   UGUAUUAAAGACCUCUUCCtg      
                                          GGAUACAAUGCAACUGUCCtt   GGACAGUUGCAUUGUAUCCtt      
  NM_177052                 Kif6          CCUGGCAGAUGGAUUCGUAtt   UACGAAUCCAUCUGCCAGGtc      Mm00723857_m1
                                          GCUUCAACCCGGUCACACUtt   AGUGUGACCGGGUUGAAGCtt      
                                          CGAAUGUGGCUAUGACCUGtt   CAGGUCAUAGCCACAUUCGtt      
  NM_010628                 Kif9          GGACUUGGUUUAUGAAACAtt   UGUUUCAUAAACCAAGUCCtg      Mm00495130_m1
                                          GCAUCGACAUCCACUUGAAtt   UUCAAGUGGAUGUCGAUGCtt      
                                          GGCUUGUCAGUGCAUCUCAtt   UGAGAUGCACUGACAAGCCtt      
  NM_010615                 Kif11         CCAUUUAAUCUGGCAGAGCtt   GCUCUGCCAGAUUAAAUGGtc      Mm01204225_m1
                                          GCUUGUUAAAAUUGGAAAGtt   CUUUCCAAUUUUAACAAGCtc      
                                          GGUCUACUGAUAUAAUCAAtt   UUGAUUAUAUCAGUAGACCtc      
  NM_010616                 Kif12         CCUGGCUAUUAGAUCGCGUtt   ACGCGAUCUAAUAGCCAGGtg      Mm00802885_m1
                                          CCUGAGUCUCGGUUCACAAtt   UUGUGAACCGAGACUCAGGtt      
                                          CCUUCACCUGGCUAUUAGAtt   UCUAAUAGCCAGGUGAAGGtc      
  NM_010617                 Kif13a        GGUAUCGUAUAUGGAGAUCtt   GAUCUCCAUAUACGAUACCtc      Mm00660179_m1
                                          GGGAAAUAAGUCUCGAACGtt   CGUUCGAGACUUAUUUCCCtc      
                                          GCUGGAGAAUAAGCUAAUUtt   AAUUAGCUUAUUCUCCAGCtt      
  NM_010620                 Kif15         GGAGUCUGUAUUCUCAACAtt   UGUUGAGAAUACAGACUCCtg      Mm01341275_m1
                                          GCGGUUAUAAUGGGACCAUtt   AUGGUCCCAUUAUAACCGCtc      
                                          GCAAACCUCAAUCUUGAAAtt   UUUCAAGAUUGAGGUUUGCtt      
  NM_010623                 Kif17         GGCAGUGGGAAGUCUUUCAtt   UGAAAGACUUCCCACUGCCtg      Mm00456740_m1
                                          GGAGGCCACCAAAAUUAACtt   GUUAAUUUUGGUGGCCUCCtt      
                                          CCCUGAUGAAUAAGGACUCtt   GAGUCCUUAUUCAUCAGGGtg      
  NM_139303                 Kif18a        GGCGGUGCAGUUCUGUAAAtt   UUUACAGAACUGCACCGCCtt      Mm01327661_m1
                                          GCCAAUCCUUCAUAGUUUUtt   AAAACUAUGAAGGAUUGGCtt      
                                          CGUGCUUAAACUUACUCCAtt   UGGAGUAAGUUUAAGCACGtt      
  NM_028547                 Kif2b         CCAAUGAACUAGUUUACCATT   UGGUAAACUAGUUCAUUGGAT      Mm01308520_s1
                                          CGACAAUACGAAUUCGGGATT   UCCCGAAUUCGUAUUGUCGTT      
                                          GCUCCAAUCACUACGAGAATT   UUCUCGUAGUGAUUGGAGCTT      
  NM_010626                 Kif7          GGAGAACGGCUCAAAGAGATT   UCUCUUUGAGCCGUUCUCCGG      Mm01320530_m1
                                          GCCUGGAGAUUGAUAGCAATT   UUGCUAUCAAUCUCCAGGCGT      
                                          CAACAGCAAAAGAUCCUGATT   UCAGGAUCUUUUGCUGUUGCT      
  NM_001081177              Kif13b        AGACGGGCAUUGUACGGUATT   UACCGUACAAUGCCCGUCUTG      Mm01314840_m1
                                          GGCUAGAAGUAACAUCUGATT   UCAGAUGUUACUUCUAGCCTC      
                                          CCAUCUCCCAUGGUGGUUATT   UAACCACCAUGGGAGAUGGAG      
  NM_001081258              Kif14         CAGGGAUGCUGUUCGGAUATT   UAUCCGAACAGCAUCCCUGCA      Not available
                                          CCUCUGUUCGAGUUCGUAATT   UUACGAACUCGAACAGAGGTA      
                                          GGAAAGUCCUAUACGAUGATT   UCAUCGUAUAGGACUUUCCAG      
  NM_001081133              Kif16b        GUACAUAAUUCAACAUAUATT   UAUAUGUUGAAUUAUGUACAT      Mm01327880_m1
                                          CACUUAGAGAAAUACCUCATT   UGAGGUAUUUCUCUAAGUGTG      
                                          GGAUUUGGAUUUAAUAAUATT   UAUUAUUAAAUCCAAAUCCAA      
  NM_001102615              Kif19a        GAAGGAGUCCUACACCAAATT   UUUGGUGUAGGACUCCUUCCT      Mm01244862_m1
                                          CAACUAUCGGGACAGCAAATT   UUUGCUGUCCCGAUAGUUGAT      
                                          CAAUCUAUCUAGCAGCACATT   UGUGCUGCUAGAUAGAUUGTC      
  NM_183046                 Kif20b        CAACGGUAGAAGUAAGUAATT   UUACUUACUUCUACCGUUGAT      Mm01205010_m1
                                          CCAACGAUCUAAGUGCAAATT   UUUGCACUUAGAUCGUUGGTT      
                                          GCGAAUAAUUUGCAUGAUATT   UAUCAUGCAAAUUAUUCGCCA      
  NM_001097621              Kif26a        UGACGAGUUUGAUGCUUAUTT   AUAAGCAUCAAACUCGUCATT      Mm01339746_m1
                                          GCCCUGAACGUAUGUCGAATT   UUCGACAUACGUUCAGGGCCT      
                                          AGAUCAAGGUGUACGAAAUTT   AUUUCGUACACCUUGAUCUCA      
  NM_009004                 Kif20a        GGACCUGUUGUCAGACUGCtt   GCAGUCUGACAACAGGUCCtt      Mm00436226_m1
                                          GGUGAAAGUUUACCUUCGAtt   UCGAAGGUAAACUUUCACCtt      
                                          CGUACACCAUUCAAGGUACtt   GUACCUUGAAUGGUGUACGtt      
  NM_016705                 Kif21a        GGAUAUUGCCAGUAAUUAAtt   UUAAUUACUGGCAAUAUCCtc      Mm00497322_m1
                                          CCCAGUGCAUCGAAAAGCUtt   AGCUUUUCGAUGCACUGGGtg      
                                          CGAAGAGAUCAGUAAUAUGtt   CAUAUUACUGAUCUCUUCGtt      
  NM_019962                 Kif21b        GGAAAAAGUUCCAAAAGAAtt   UUCUUUUGGAACUUUUUCCtg      Not available
                                          GGAGAAGAUGCUGUCUUGCtt   GCAAGACAGCAUCUUCUCCtt      
                                          GGCUGCUCAAAAAGAACAUtt   AUGUUCUUUUUGAGCAGCCtg      
  NM_145588                 Kif22         GGAAGUCUAUGUAGGUUCAtt   UGAACCUACAUAGACUUCCtg      Mm01139072_m1
                                          GGGCAGAAUGCCAGUGUACtt   GUACACUGGCAUUCUGCCCtt      
                                          GGAAAACUCUACCUUAUUGtt   CAAUAAGGUAGAGUUUUCCtt      
  NM_024245                 Kif23         GGGCUAUCGACUCAACAGAtt   UCUGUUGAGUCGAUAGCCCtc      Mm00458527_m1
                                          GGAAAAAGAGCAAAUUACUtt   AGUAAUUUGCUCUUUUUCCtg      
                                          GCAUAGGGUCAUUUCAAGCtt   GCUUGAAAUGACCCUAUGCtg      
  NM_024241                 Kif24         GCCAAGAGGACAUUUGGCAtt   UGCCAAAUGUCCUCUUGGCtg      Mm01211351_m1
                                          CCAGCAUUCACCUGACAAAtt   UUUGUCAGGUGAAUGCUGGtg      
                                          GCAUGUGGUACAGAUAGCUtt   AGCUAUCUGUACCACAUGCtt      
  NM_177757                 Kif26b        GGAGAGAGAUGAAAUUUGAtt   UCAAAUUUCAUCUCUCUCCtt      Not available
                                          CCUUCGAGACCUGUUGUCUtt   AGACAACAGGUCUCGAAGGtt      
                                          GCUCUCAGCAAAAACCGAGtt   CUCGGUUUUUGCUGAGAGCtt      
  NM_175214                 Kif27         GGAUCUCUACUUCUAUAAGtt   CUUAUAGAAGUAGAGAUCCtt      Mm00723524_m1
                                          GGCCAUGUUGCAUCAGUUGtt   CAACUGAUGCAACAUGGCCtc      
  NM_053173                 Kifc1         GGCUAAUAAGAAGUGAAGUtt   ACUUCACUUCUUAUUAGCCtg      Mm03011779_m1
                                          GGAACUGAAGGGCAAUAUCtt   GAUAUUGCCCUUCAGUUCCtg      
                                          GGCCAUUAACAGCAGUCUGtt   CAGACUGCUGUUAAUGGCCtg      
  NM_010630                 Kifc2         GGAGGAACAGAGAGUUUGGtt   CCAAACUCUCUGUUCCUCCtc      Mm00495161_m1
                                          GGUCAACCUUUAAAAAACAtt   UGUUUUUUAAAGGUUGACCtg      
                                          GCUGAGUAGACUUCGUCUGtt   CAGACGAAGUCUACUCAGCtc      
  NM_010631                 Kifc3         GGGCAUGUAUAUAAUGUUCtt   GAACAUUAUAUACAUGCCCtg      Mm00516085_m1
                                          CGACUACAAUGGGCUCAAGtt   CUUGAGCCCAUUGUAGUCGtt      
                                          GGUUAAUAGCAACAACCAGtt   CUGGUUGUUGCUAUUAACCtc      
  NM_008451                 Klc2          GGCGGUGAUCCAGGGUUUAtt   UAAACCCUGGAUCACCGCCtt      Mm00492945_m1
                                          GGGUUUAGAGACCCUGAGAtt   UCUCAGGGUCUCUAAACCCtg      
                                          GGUGGUAGAACUGUUAAAAtt   UUUUAACAGUUCUACCACCtt      
  NM_146182                 Klc3          CAAAUGUGGCCAAGACUAAtt   UUAGUCUUGGCCACAUUUGgg      Mm00461422_m1
                                          GGAGGCUAGCCCAAGAGAAtt   UUCUCUUGGGCUAGCCUCCgt      
                                          AUGGAAAACGUGGACGUUAtt   UAACGUCCACGUUUUCCAUag      
  NM_001025360              Klc1          GGAGGAGAAGAAACACCUGtt   CAGGUGUUUCUUCUCCUCCtc      Mm00492936_m1
                                          CCUAGCAGUACUGUACGGUtt   ACCGUACAGUACUGCUAGGtt      
                                          GGGAUCAGAACAAGUAUAAtt   UUAUACUUGUUCUGAUCCCtg      
  NM_197959                 Kif18b        CGAGCGGAUGCUGGUAUUUtt   AAAUACCAGCAUCCGCUCGtc      Mm01253048_g1
                                          GCCGAGCAGUUACUUGAGAtt   UCUCAAGUAACUGCUCGGCtg      
                                          CCUACGAGGAUACUUACAAtt   UUGUAAGUAUCCUCGUAGGtc      
  NM_173762                 Cenpe         GGUUCAAGAACUUAAGACAtt   UGUCUUAAGUUCUUGAACCtt      Mm00620549_m1
                                          GGAAAUGCUCAAAGAUUUUtt   AAAAUCUUUGAGCAUUUCCtc      
                                          GGAUUACUGAUCUCCAAAAtt   UUUUGGAGAUCAGUAAUCCtt      
  NM_030238                 Dync1h1       GGAGAAAGAAUUCAUUUCCtt   GGAAAUGAAUUCUUUCUCCtc      Mm00466548_m1
                                          GCUCCUGUGAUUGAUGCAGtt   CUGCAUCAAUCACAGGAGCtc      
                                          GGAGGUUAUGUUUAAAACUtt   AGUUUUAAACAUAACCUCCtc      
  NM_010063                 Dync1i1       GGAAGAGGAGAGGAAGAAGtt   CUUCUUCCUCUCCUCUUCCtt      Mm01135515_m1
                                          CCCAAAAUUGGUCAUGAUUtt   AAUCAUGACCAAUUUUGGGtt      
                                          GGAAGAAAAACAGCAGAUCtt   GAUCUGCUGUUUUUCUUCCtc      
  NM_010064                 Dync1i2       CCAUUCUACGAGAAUUGUAtt   UACAAUUCUCGUAGAAUGGtc      Mm01333946_m1
                                          GCAGAUUAACAUCUUCUUUtt   AAAGAAGAUGUUAAUCUGCtc      
                                          GGAAAGGAAAAAAAAGGAAtt   UUCCUUUUUUUUCCUUUCCtc      
  NM_007835                 Dctn1         CCACAUCAAGUUCACCCAGtt   CUGGGUGAACUUGAUGUGGtc      Mm01184845_m1
                                          GGAAGUAUUUCACAUGUGAtt   UCACAUGUGAAAUACUUCCtt      
                                          CCUGGAAACAUCAUGUAGUtt   ACUACAUGAUGUUUCCAGGtc      
  NM_019682                 Dynll1        GGAGUUUGACAAGAAGUACtt   GUACUUCUUGUCAAACUCCtt      Mm00850282_g1
                                          GGUGGCCAUUCUUCUGUUCtt   GAACAGAAGAAUGGCCACCtg      
                                          GGACUGCAUCCAAAUUCCAtt   UGGAAUUUGGAUGCAGUCCtt      
  NM_009342                 dynlt1        GGAACCACAUGACUUCAGCtt   GCUGAAGUCAUGUGGUUCCtg      Not available
                                          GGCAGUACCACUUGUCUUAtt   UAAGACAAGUGGUACUGCCtg      
                                          GGUGCUAAAAACUCAAGUCtt   GACUUGAGUUUUUAGCACCtt      
  NM_025975                 Dynlt3        GCAUAGUGGAACAGUCUAUtt   AUAGACUGUUCCACUAUGCtt      Mm00458834_m1
                                          GGCCAUUAACUUAAGUUUGtt   CAAACUUAAGUUAAUGGCCtt      
                                          GCCCGUAUGGAUUUCACACtt   GUGUGAAAUCCAUACGGGCtc      
  NM_025947                 Dynlrb1       CCUUCCUUCGAAUUCGCUCtt   GAGCGAAUUCGAAGGAAGGtt      Mm00508951_m1
                                          GGCUUUGGAAUGAGAGCUUtt   AAGCUCUCAUUCCAAAGCCtg      
                                          GGCAUUCCCAUCAAGAGCAtt   UGCUCUUGAUGGGAAUGCCtt      
  NM_026556                 Dynll2        GGCCAUGGAGAAGUACAACtt   GUUGUACUUCUCCAUGGCCtg      Not available
                                          GGACAUUGCUGCCUAUAUCtt   GAUAUAGGCAGCAAUGUCCtt      
                                          GGUCUGAAGUAUAGCAAUGtt   CAUUGCUAUACUUCAGACCtg      
  NM_029297                 dylnrb2       GGAAUAUCUUCUGAUUGUCtt   GACAAUCAGAAGAUAUUCCtt      Mm00466467_m1
                                          CGAAUCCAUGAUAUUGUACtt   GUACAAUAUCAUGGAUUCGtg      
                                          CGACCUGACUUUUCUUAGGtt   CCUAAGAAAAGUCAGGUCGtt      
  NM_146229                 dync1li1      CCGGCUAAGAAAGACAAUUtt   AAUUGUCUUUCUUAGCCGGtc      Mm01353886_m1
                                          GCUACAGUCUCUUUUAGCAtt   UGCUAAAAGAGACUGUAGCtt      
                                          GCCUUGGACUGCUUUGGAUtt   AUCCAAAGCAGUCCAAGGCtt      
  NM_001013380              dync1li2      GCAGGUUAAGUAGCUGACAtt   UGUCAGCUACUUAACCUGCtt      Dync1li2
                                          CGUGCUGACUCAUAACCUGtt   CAGGUUAUGAGUCAGCACGtt      
                                          CGUAGCACUUCUUCUCUUAtt   UAAGAGAAGAAGUGCUACGtt      

We found eight minus end--directed motors or associated proteins and 11 plus end--directed motors involved in at least one nuclear movement behavior ([Figure 2B](#F2){ref-type="fig"}), suggesting a high degree of complexity for the regulation of nuclear positioning in muscle cells. Several motors affect only one nuclear behavior; depletion of members of the kinesin-3 family (Kif13a, Kif13b), the dynein heavy chain (Dync1h1), and the dynein light chain LC8-type2 (Dynll2) solely increase nuclear speed. Kif13a and Kif13b are mainly involved in endosome trafficking ([@B13], [@B14]). However, recent evidence demonstrated that the *Drosophila* homologue of Kif13b, khc73, is implicated, together with dynein heavy chain, in spindle positioning by anchoring MTs to the cell cortex ([@B23]). We previously showed that dynein is important in nuclear centration movement, probably through its localization at the nuclear envelope ([@B8]). In contrast, others found that depletion of dynein reduces nuclear speed in myotubes ([@B34]). These differences may stem from the fact that their measurements were done 168 h after differentiation, when nuclear movement characteristics (speed and percentage of time in motion) could be different from those in our analysis (60 h after differentiation). Because Dynll2 is involved in the formation of the dynein complex ([@B26]), its identification as playing a role in nuclear speed is in agreement with previous reports and emphasizes the connection between dynein and Kif13b.

The time in motion of nuclei was reduced exclusively after silencing of Kif26a, Kif27, Dync1i1, Dync1i2, or Dync1li2. Little is known about the function of Kif26a and Kif27, whereas Dync1i1, Dync1i2, and Dync1li2 are cargo adapters for dynein. Their absence could thus induce a delay in the recruitment of motors involved in moving the nucleus.

A few motors affect two types of nuclei behavior without altering others. Kif4 knockdown before differentiation leads to a decrease in speed and time in motion. Kif4 is known to be involved in the alignment of MTs in *Xenopus* ([@B25]) and might have the same activity during myotube formation. Depletion of Kifc1, Kifc2, Dynlrb1, or Dynll1 affects both nuclei speed and time in motion but does not perturb nuclei alignment ([Figure 2A](#F2){ref-type="fig"}). Kifc1, also known as HSET, is as a centrosome-clustering protein in cancers with supernumerary centrosomes ([@B10]) but is also capable of transporting the MT minus-end protein γ-tubulin ([@B22]). Because there is a relocalization of MT nucleation toward the nuclear envelope and a disappearance of centrosomes during differentiation ([@B29]), Kifc1 might affect these events and thereby perturb normal nuclear positioning.

Unexpectedly, knockdown of kinesin light chain 1, 2, or 3 did not effect nuclear movement or organization. As previously suggested, however, redundancy of Klc1 and 2 may require double knockdown of these proteins to observe an effect on nuclear aggregation ([@B35]).

As expected, only knockdown of the motor protein Kif5b altered the three types of nuclear behavior ([Figure 2A](#F2){ref-type="fig"}). Kif5b was already implicated in nuclear rotation, movement, and positioning in muscle cells ([@B24]; [@B34], [@B35]). Kif5b was also identified as the kinesin responsible for basally directing nuclear movement in neurons and thus contributing to neurogenesis ([@B31]).

Motors affecting nuclear alignment
----------------------------------

Because nuclear alignment might depend on a complex mechanism, we decided to focus our attention on the five motor proteins whose depletion affects nuclei alignment: Kif5b, Kif1c, Kif1a, Kif9, and Kif21b. Kif9 couples centrosomes to nuclei ([@B30]). Kif1a and Kif1c are mutated in spastic paraplegia ([@B6]; [@B16]; [@B11]), and Kif1a is associated with interkinetic nuclear movement in the developing brain ([@B31]; [@B9]). Finally, Kif21b knockdown increases nuclear alignment in myotubes.

We therefore further analyzed these phenotypes by measuring the spreading factor, that is, the ratio between the average observed distances between nuclei and the theoretically optimal distance. We found a similar reduction of this ratio in Kif5b-, Kif1a-, and Kif1c-knockdown myotubes ([Figure 2C](#F2){ref-type="fig"}). Unexpectedly, this factor was nearly unchanged in myotubes depleted for Kif9 or Kif21b. Kif9-silenced myotubes display aggregated nuclei, but the phenotype is different from the one observed in Kif5b- or Kif1a-depleted myotubes. In the kif9 siRNA cohort, nuclei form distinct clusters along the length of the myotube, yielding a higher average distance between nuclei than in Kif5b-knockdown myotubes ([Figure 2, C and E](#F2){ref-type="fig"}, and Supplemental Figure S2D). Concerning Kif21b depletion, the increase in the percentage of myotubes with aligned nuclei does not imply an increase in nuclear spreading.

To understand whether these motors affect differentiation, we measured, besides the fusion index (Supplemental Figure S1CD), the number of nuclei per myotube, which represents myotube size ([Figure 2D](#F2){ref-type="fig"}). Kif5b or Kif9 depletion shows an increase in the fusion index while maintaining a normal number of nuclei per myotube. This suggests that even if kif5b and kif9 affect nuclear positioning, they do not interfere with the myogenic program. On the other hand, Kif1a or Kif1c depletion does not affect the fusion index but affects the number of nuclei per myotube. The most plausible explanation is that this result stems from a reduction in the number of cells available for fusion. Kif1a or Kif1c must therefore have an effect on the cycle of division before differentiation. Nevertheless, both motors remain interesting candidates for nuclear aggregation. Finally, Kif21b depletion decreases both the fusion index and the number of nuclei per myotube, suggesting a dual role, one for nuclear alignment and one for differentiation.

MT motors could affect nuclear movement and positioning by modifying MT organization or dynamics. To answer this question, we analyzed the orientation and length of EB1 comets in myotubes over a period of 200 s after depletion of a few motors (Supplemental Figure S1, D and E). This quantification of the MT growing plus ends allowed us to estimate the dynamics of the MTs and their organization. Most MTs grow parallel to the longest axis of the myotube (Supplemental Figure S1D). Only slight modifications in comet orientation were found after depletion of Kif5b or Dynlrb1, which could correlate with the observed differences in nuclear behavior. Surprisingly, the lengths of the EB1 comets were significantly modified after depletion of several motors without any correlation to their individual effects on nuclear movement (Supplemental Figure S1E). We hypothesize that normal nuclear movement might rely on different aspects---an oriented MT network, dynamic MTs, and molecular motors---to produce the necessary forces.

The nucleus represents the biggest organelle in the cell, and these findings illustrate the complexity required to move as well as organize the distribution of multiple nuclei in a large muscle cell. Several interesting candidates remain to be explored for their specific role, such as the proteins affecting two parameters of nuclear behavior. This opens new routes of research toward understanding intracellular organization.

MATERIALS AND METHODS
=====================

Cell line
---------

C2C12 cells were cultured in DMEM with 10% fetal bovine serum (Invitrogen) and antibiotics (penicillin at 100 U/ml and streptomycin at 100 μg/ml) and were plated on 0.1% gelatin-coated dishes or acid-washed coverslips for 1--2 d before differentiation. Differentiation was induced by switching to DM (DMEM with 1% horse serum).

Chemicals and plasmids
----------------------

Drugs were applied on 48-h-differentiated C2C12 cells and directly time-lapse recorded during 10 h. STA parameters were quantified during this time period. Taxol was from Calbiochem (580555), nocodazole from Sigma-Aldrich (M1404), cytochalasin D from Calbiochem (250255), and jasplakinolide from Santa Cruz Biotechnology (sc-202191A). YFP-Δ-227-spastin (C-terminus truncation) was a gift from Brett Lauring (Columbia University, New York).

siRNA transfection
------------------

Cells were transfected with three different siRNAs per gene using RNAiMAX, following the manufacturer's instructions (Life Technologies), 2 d before differentiation. For spastin cDNA transfection, we used Lipofectamine 2000 (Life Technologies), and cells were switched to DM 12 h after transfection. siRNAs were obtained from Life Technologies (primers used are listed in [Table 1](#T1){ref-type="table"}).

Microscopy
----------

Epifluorescence images were acquired using a Nikon Ti microscope equipped with a CoolSNAP HQ2 camera (Roper Scientific) and an *XY*-motorized stage (Nikon) driven by MetaMorph (Molecular Devices). Multipositioning images were stitched with MetaMorph. For live imaging, we used an incubator to maintain cultures at 37°C and 5% CO~2~ (Okolab).

Quantification of nuclear movement and positioning inside myotubes
------------------------------------------------------------------

We used the SkyPad algorithm as previously described ([@B7]) to quantify speed and time in motion. Briefly, nuclei centroids positions were manually picked every 15 min over 15 h, and coordinates were transferred to an Excel spreadsheet before running the SkyPad algorithm. For nuclear positioning, we identified three possible situations: nuclei are spread along the myotube axis (aligned), nuclei are clustered together (aggregated), and there is a mix of both (other). To calculate the spreading factor, we measured the nuclei interdistances and the length of the myotube. The spreading factor is the observed average interdistance over the optimal interdistance, that is, the myotube length divided by the number of nuclei.

Quantification of fusion index and number of nuclei per myotubes
----------------------------------------------------------------

The fusion index was calculated as percentage of nuclei found inside myotubes (more than two nuclei) over the total number of nuclei present in the same area (3.79 mm^2^) at the end of each movie, 88 h after switching to differentiation medium.

Validation of siRNA knockdown by Western blot and reverse transcription quantitative PCR
----------------------------------------------------------------------------------------

At 48 h after silencing, cells were lysed in 1% SDS in phosphate-buffered saline (PBS) and passed through Qiashredder columns. Equal amounts of proteins were loaded on 4--12% gradient gels, followed by transfer on nitrocellulose membrane using the iBlot apparatus (Life Technologies). Primary antibodies were from Bethyl (Kif1b, Klc2), BD (Dcnt1), and Santa Cruz Biotechnology (kif5b). mRNAs from C2C12 cells were isolated with the RNeasy 96 Kit (Qiagen), and cDNA was prepared with the High-Capacity cDNA Reverse Transcription Kit (Life Technologies). Quantitative PCR (qPCR) analyses were performed using Taqman Gene Expression assay (Life Technologies; see [Table 1](#T1){ref-type="table"}) in a StepOne Plus system (Applied Biosystems). For Kif5b, Kif1a, and Kif26b, mRNAs from C2C12 cells were isolated with the RNeasy Micro Kit (Qiagen), and cDNA was prepared with the Transcriptor First-Strand cDNA Synthesis Kit (Roche). qPCR was performed using a CyberGreen Kit in a LightCycler 480 II system (Roche), using the following primers: Kif5b-F, 5′-GGAGGCAAGCAGTCGTAAAC-3′; Kif5b-R, 5′-TCTAGTGTTGGGAAGCAGCA-3′; Kif1a-F, 5′-GAAG­ACTCCCTCCCCTGTTC-3′, Kif1a-R, 5′-ATCTCTCCACCGTGTCC­TTG-3′, Kif26b-F, 5′-TGGGGAACCATTCGAAATTA, Kif26b-R, 5′-AGGACCTGCTCCAAGTCAAA-3′; Hprt1-F, 5′-GTTAAGCAGTACAGCCCCAAA-3′; and Hprt1-R, 5′-AGGGCATATCCAACAACAAACTT-3′.

Statistics
----------

A Gaussian distribution of averaged speeds of each nucleus was tested using the D'Agostino and Pearson omnibus normality test for each condition (GraphPad software); it appeared that the distribution was not Gaussian, and so the statistical significance between conditions was measured using the Mann--Whitney test for non-Gaussian distributions. A normal Student's *t* test was used otherwise.
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GFP

:   green fluorescent protein

MT

:   microtubules

siRNA

:   small interfering RNA.
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